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Abstract
Whole- genome sequencing is becoming the de facto standard for bacterial outbreak surveillance and infection prevention. This 
is accompanied by a variety of bioinformatic tools and needs bioinformatics expertise for implementation. However, little is 
known about the concordance of reported outbreaks when using different bioinformatic workflows. In this multi- centre profi-
ciency testing among 13 major Dutch healthcare- affiliated centres, bacterial whole- genome outbreak analysis was assessed. 
Centres who participated obtained two randomized bacterial datasets of Illumina sequences, a Klebsiella pneumoniae and a 
Vancomycin- resistant Enterococcus faecium, and were asked to apply their bioinformatic workflows. Centres reported back 
on antimicrobial resistance, multi- locus sequence typing (MLST), and outbreak clusters. The reported clusters were analysed 
using a method to compare landscapes of phylogenetic trees and calculating Kendall–Colijn distances. Furthermore, fasta 
files were analysed by state- of- the- art single nucleotide polymorphism (SNP) analysis to mitigate the differences introduced 
by each centre and determine standardized SNP cut- offs. Thirteen centres participated in this study. The reported outbreak 
clusters revealed discrepancies between centres, even when almost identical bioinformatic workflows were used. Due to strin-
gent filtering, some centres failed to detect extended- spectrum beta- lactamase genes and MLST loci. Applying a standardized 
method to determine outbreak clusters on the reported de novo assemblies, did not result in uniformity of outbreak- cluster 
composition among centres.
DATA SUMMARY
K. pneumoniae and E. faecium Illumina sequence data is avail-
able via BioProject PRJEB15226 and PRJEB25424, respec-
tively. For a full list of the accession numbers, see Table S1 
(available in the online version of this article). Proficiency test 
template sheets and associated code are available at ‘https:// 
github. com/ MUMC- MEDMIC/ SIGBIO- proficiencytest’ 
under an MIT license.
INTRODUCTION
Dissemination of pathogenic bacteria is a significant contrib-
utor to healthcare- associated infections (HAI) and a global 
problem. For intensive care (IC) admitted patients, 11 787 
(8.3 %) patients acquired a HAI in Europe in 2017 alone [1]. 
Infections by antimicrobial- resistant bacteria are an increased 
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Of significant interest are the ESKAPE pathogens (Entero-
coccus faecium, Staphylococcus aureus, Klebsiella pneumoniae, 
Acinetobacter baumannii, Pseudomonas aeruginosa and 
Enterobacter sp.), as they are associated with a burden on 
the economy and adverse outcomes for hospitalized patients 
[2, 3]. Therefore, it is essential to curb the dissemination 
and infections of these nosocomial pathogens by employing 
proper infection- prevention measurements and typing strat-
egies to strengthen surveillance in and around healthcare 
facilities.
Conventional typing methods such as PFGE [4], multi- locus 
sequence typing (MLST) [5] and amplification fragment length 
polymorphism (AFLP) [6] have been used for many years to 
perform outbreak analysis and made bacterial epidemiology 
possible. These methods are robust and have well- defined 
guidelines [7]. Nowadays, whole- genome sequencing (WGS) 
has become common, as an increased number of laboratories 
have adopted it. The versatility, backward compatibility and 
ability to measure at a detailed genomic level are significant 
contributors to its increased implementation [8–13], thereby 
phasing out conventional typing methods.
WGS provides genomic data, which can be used to find 
genetic sample- to- sample relations [14–16]. WGS outbreak 
analysis is more and more applied by hospital Infection 
Prevention Control (IPC) teams to trace and monitor patho-
genic infections [17–20] but also to traceback the source 
of transmission [21, 22]. Additionally, with WGS, one can 
detect antimicrobial resistance (AMR) genes and virulence 
factors, which is a beneficial add- on for clinicians and IPC 
[11]. To perform bacterial whole- genome- based outbreak 
analysis, WGS for data needs pre- processing using either one 
of three strategies or a combination. (i) Reference- based: by 
mapping sequence reads to a reference genome and detect 
single- nucleotide polymorphisms (SNPs). (ii) Allelic- 
based: by determining the allelic content and comparing 
these alleles between strains, commonly referred to as core 
genome (cg) or whole genome (wg) MLST. (iii) k- mer based: 
genomic data is grouped into smaller sequences of length k, 
and the composition of those shorter sequences is used to 
detect SNPs. To accompany these strategies, a vast amount 
of bioinformatic tools are available [10]. To date, guidelines 
or quality markers for WGS outbreak analysis in nosocomial 
settings are still in its infancy. However, minimal sequencing 
quality requirements and well- defined quality markers are 
needed to harmonize laboratories and make inter- laboratory 
comparisons possible [23].
Previous studies have provided insights into the inter- 
laboratory comparison of WGS data. A study that assessed 
the reproducibility of WGS- based typing by performing a ring 
trial with multiple centres concluded that WGS- based typing 
is reproducible for Staphylococcus aureus [24]. Studies show 
that the identification of AMR genes is reproducible [25]. 
However, the translation to phenotype is inconsistent [26].
A third initiative is ongoing and initiated by The Swiss Insti-
tute of Bioinformatics. They are performing a nationwide 
quality assessment ring trial focusing on bacterial phylogeny 
to eventually start a nationwide WGS outbreak surveillance 
platform [23].
The variety in bioinformatic workflows for outbreak analyses 
applied by these studies only reflects a small portion of the 
total diversity of procedures used among centres. However, 
little is known about the congruence of identifying bacterial 
outbreaks among these various bioinformatic workflows.
This study assessed the comparability of bacterial outbreak 
analyses and outcomes performed by multiple centres in the 
Netherlands. We aim to (i) expose the differences in bioinfor-
matic workflows applied by centres and their effect on cluster 
composition, (ii) present a strategy to assess performance 
between centres by using an advance analysis methodology 
that is easy to implement and interpret, and (iii) provide 




Illumina paired- end sequencing data was obtained from the 
Sequence Read Archive (SRA) and extracted using fasterq- 
dump (- F -S) (https:// github. com/ ncbi/ sra- tools/ tree/ 
master/ tools/ fasterq- dump). For both K. pneumoniae and 
E. faecium, 40 random datasets were selected from BioProject 
PRJEB15226 [27] and PRJEB25424, respectively. To the best 
of our knowledge, no publicly available outbreak analysis 
was conducted previously on these samples. File names and 
Impact Statement
Bacterial typing and outbreak analyses are essential 
for performing appropriate infection prevention control. 
Whole- genome sequencing (WGS) is quickly becoming 
the gold standard in the field, notwithstanding the bioin-
formatic tools used to process the data and interpret 
the phylogenetic relation between the bacterial patho-
gens are currently not standardized. To date, it remains 
unclear what impact the use of these different tools has 
on the typing outcome and interpretation of outbreaks 
between different centres. In this study, we performed a 
proficiency test that focuses on the impact of different 
bioinformatic tools applied by centres on interpreta-
tion and possible infection- prevention decision making. 
The results of this study contribute to the community 
by: (i) exposing the extend of variations in WGS analysis 
resulting from usage of different bioinformatics tools, 
parameters and interpretation thresholds; (ii) highlighting 
the shortcomings of certain bioinformatic tools and deci-
sions; (iii) providing insights on how to improve bacte-
rial typing. We bring to light that it is essential to apply 
identical bioinformatic workflows to make it possible to 
implement inter- laboratory surveillance on regional or 
national level and thus improve future outbreak analysis.
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FASTQ headers were anonymized before distribution to the 
centres. For a full list of the accession numbers, sample details 
and metadata, see Table S1.
Standardisation of reporting
A secure data transferring service ( www. surffilesender. nl) was 
used to provide each participating centre three standardized 
excel report files including an instruction manual. The first 
excel file is a pipeline report file in which the participants 
describe their pipeline(s), QC rejection parameters, and 
cluster cut- offs applied on the datasets. The second and third 
files are sheets for KP and VRE, respectively, in which the 
participants report genome coverage, MLST and presence 
of AMR genes for each sample in the dataset, as well as the 
sample- to- sample relation based on clonal relatedness. Partic-
ipants used their routine methods and thresholds for analysis. 
Participating centres were asked to fill in their analysis results 
in the report sheets and fill out their contact details. All excel 
sheets were parsed using python (version 3.7.6) and jupyter 
(version 4.6.1) using pandas (version 0.25.3) and NumPy 
(version 1.17.3). When necessary, manual inspection of 
assemblies was done using ABRicate (version 0.9.8) [28] or 
mlst (version 2.19.0) [29], and inspection of reads was done 
using KMA (version 1.2.26) [30] and the Resfinder database 
(accessed 18 June 2020). These template sheets and associated 
code are available at https:// github. com/ MUMC- MEDMIC/ 
SIGBIO- proficiencytest.
Reporting of outbreak clusters
Participants registered the outbreak clusters by inserting 
values in the lower triangle of a similarity matrix by placing 
either 0, 0.5 or 1, which indicates for ‘not related’, ‘probably 
related’ or ‘related’, respectively. The lower triangle similarity 
matrix was converted to a square similarity matrix using 
python. The instruction manual explicitly stated that all 
strains in a cluster should be related to each other to be part of 
a cluster. A custom python script (available at https:// github. 
com/ MUMC- MEDMIC/ SIGBIO- proficiencytest), imple-
menting networkx (version 2.4), was used to correct these 
missing relations. With this script, sample- to- sample relations 
were represented in a network graph, and missing edges were 
restored between samples to complete the outbreak clusters. 
For example, if sample A is clonally related to sample B, and 
sample B clonally related to sample C, sample A and C are 
also part of the cluster. This missing edge was added in the 
graph between samples A and C to complete all edges within 
a cluster. The resulting network graph was converted into a 
dissimilarity matrix for subsequent analyses. This process was 
manually inspected before applying to all reported results. 
Sample- to- sample relations, as reported by all centres, are 
aggregated and visualized using Cytoscape (version 3.7.2) 
using Prefuse Force Directed OpenCL Layout [31].
Creating additional matrixes
A summed distance matrix (SDM) was calculated by summing 
all the reported dissimilarity matrices per species. A majority 
distance matrix (MDM) was constructed by selecting values 
in the SDM that scored higher than half of the number of 
participating centres (>6.5). Thereby, maintaining only the 
sample- to- sample relations which represent the majority vote.
Compare outbreak clusters among centres
Dissimilarity matrices per centre and MDM were imported 
in R (version 3.6.3). Dissimilarity trees were inferred by using 
UPGMA with hclust (version 3.6.3). A geometric median 
of all dissimilarity trees, according to the Kendall–Colijn 
metric, was calculated by using the function medTree of the 
R package treespace (version 1.1.3.2) [32, 33]. Additionally, 
all trees, including the MDM tree, were compared using the 
multiDist function of R package treespace per species. This 
resulted in a pairwise distance matrix of all trees calculated 
using the Kendall–Colijn metric [32]. The pairwise distance 
matrix was used as input for hclust to create a UPGMA tree- 
of- centres. Visualization of the trees and metadata was done 
using iTOL (version 5.5.1).
Perform SNP-cut-off sweep
Pairwise core- and whole- genome SNPs (cgSNPs, wgSNPs) 
was used to determine if standardized cut- offs mitigate cluster 
composition variation. The fasta files of all de novo assemblies 
provided by each centre were used as input. The pairwise 
SNPs were calculated by split k- mer analyses as implemented 
by SKA (version 1.0) [34]. In short, split k- mer files (.skf) were 
generated for each assembly (ska fasta, default parameters). 
For cgSNPs we only maintained split k- mers that were present 
in 90 % of all assemblies per dataset. Pairwise alignments 
were made (‘ska align -p 0.9’), and the SNP distance was 
determined using snp- dists (version 0.7.0) [35]. For wgSNP 
analysis, pairwise SNP distance was determined directly from 
the .skf files (‘ska distance’). The pairwise cg- and wgSNPs 
were imported into R (version 3.6.3), and a sweep cut- off was 
applied by setting the cut- off to a range from 0 to 150 SNPs. 
Samples equal to or within this cut- off were set to be part of 
an outbreak cluster. Additionally, all strains in an outbreak 
cluster were related to each other to be consistent with the 
proficiency test method using R package igraph (version 
1.2.5) [36]. Centres were compared to each other by calcu-
lating the Kendall–Colijn distance metric using the multiDist 
function of R package treespace.
RESULTS
Thirteen centres who are members of the Special Interest 
Group Bioinformatics in Medical Microbiology (SIG- BIMM) 
NL Consortium participated in this study.
Sequence types
Participating centres were asked to report on conventional 
MLST. All 13 centres reported on sequence types (ST). Good 
concordance among centres on the reported STs was observed 
for both the KP and the VRE dataset, and for 35/40 (87.5 %) 
and 38/40 (95 %) samples, no discrepant STs were reported 
for KP and VRE, respectively.
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For the KP dataset, centre 3 may have switched sequence data 
of KP12 with KP13 and KP23 with KP24 (Table S2). Centre 5 
reported on the least number of STs for K. pneumoniae 32/40 
(80 %) and was the only centre using BioNumerics (Applied 
Maths, Belgium). This centre mentioned that for some of 
the isolates no ST could be identified because not all seven 
required alleles were called.
Centres 2, 5, 7, 11 and 13 mentioned sample KP23 not 
belonging to the K. pneumoniae species but to Klebsiella vari-
icola, a different species in the Klebsiella pneumoniae complex 
[37]. Interestingly, of the seven centres (2, 3, 4, 6, 8, 9, 10 and 
12) using Ridom SeqSphere+, only centre 2 identified sample 
KP23 as K. variicola. For KP33, two centres (2, 11) reported 
it as ST33, and five centres (1, 2, 9, 10 and 13) appointed it to 
a novel sequence type.
For the VRE set, only centre 9 reported on a discordant ST 
for VRE18 and VRE33 (Table S3). Manual inspection of 
the assembled contigs for these two datasets from centre 9 
revealed for VRE18, an incomplete pstS gene (548 bp /583 bp) 
at the end of a contig. For VRE33, no pstS was identified. The 
absence of this allele leads to an entirely new ST [38].
AMR reporting
We focus on beta- lactamase and vancomycin resistance 
genes as they are most clinically relevant. Eleven out of 
thirteen centres reported the presence of AMR genes. For 
AMR reporting in the KP dataset, the blaCTX- M genes were in 
concordance among all centres for 30 out of the 40 isolates 
(Table S4). For KP07 and KP09 centre 9, and for KP23 centre 
11 did not report a blaCTX- M gene. For KP34, only seven out of 
eleven centres managed to detect a blaCTX- M-14. The presence of 
blaCTX- M-14 in KP34 using KMA [30] was confirmed. In addi-
tion, manual inspection using ABRicate confirmed this gene 
was absent in the de novo assembly of the centres, which did 
not report blaCTX- M-14. These centres filtered out contigs smaller 
than 1 kb from the de novo assembly (data not shown). For 
blaOXA genes, all centres were in complete agreement except for 
strain KP09, for which centre 9 did not report a blaOXA-1 gene. 
For blaTEM genes, mainly blaTEM-1 was reported, and centre 1 
reported on blaTEM-30 instead of blaTEM-1. Centres reported a 
high heterogeneity on blaSHV gene variants, as only in six out 
of forty samples, a single variant was reported. Centre 5 was 
the only centre indicating the presence of blaSHV-38, a beta- 
lactamase with carbapenemase activity for strain KP12 and 
KP30. Two centres (2 and 9) reported multiple blaSHV genes 
per strain for most of the K. pneumoniae strains in this study. 
This could be reproduced using the web service of ResFinder, 
for which multiple blaSHV genes were reported on the same 
genomic location.
For the VRE dataset, 11 out of 13 centres reported on AMR 
genes. Here, although variation on reporting the vanA or 
vanB cassette, all centres agreed on the presence of vanco-
mycin resistance gene variant A or B per strain (Table S5). 
Seven out of eleven centres reported directly on the vanHAX 
or vanHBX cassette, and the remaining four centres reported 
on all separate van genes present on this cassette, including 
vanS, vanR, vanY and vanZ genes.
Pipeline descriptions
Ten out of thirteen centres used an allele calling method 
for detecting outbreak clusters, of which eight centres used 
Ridom SeqSphere+varying from version 4.1.9 to version 
6.0.2, centre 5 used the BioNumerics (version 7.6.3) software 
suite for outbreak analysis, and centre 1 used Pathogenwatch 
(https:// pathogen. watch). For allele calling, six and four 
centres used cgMLST, wgMLST, respectively. The remaining 
three centres used an SNP approach (centre 7, 11 and 13). The 
tools used for SNP- based outbreak analysis are either SKA or 
kSNP3 (Fig. 1).
Reported sample-to-sample relations and outbreak 
clusters
All reported sample- to- sample relations were aggregated to 
assess if centres reported the same outbreak clusters. In Fig. 2, 
the sum of all sample- to- sample relations are illustrated. For 
the KP dataset, we identified six independent clusters as 
defined by the majority of the centres. Contrarily, centres 1 
and 11 reported a link between KP19 and KP27. Further-
more, only centre 5 reported sample KP24 as being part of 
cluster C1. Of all six majority clusters, only cluster 6 (C6) was 
reported by all centres.
For the VRE dataset, six independent clusters were identi-
fied when using the majority vote. Firstly, centre 9 reported 
sample- to- sample relations between clusters that other 
centres identified as separate clusters: C1, C2 and C3. 
Centres 4 and 10 reported a maybe relation between two 
clusters: C1 and C3. Multiple centres linked sample VRE34 
to C2, reported as related (centres 2, 3, 4 and 8), may be 
related (centres 6, 9 and 10) and not related (centres 1, 5,7, 
11, 12 and 13). All but centre 4 reported C4. In C5, the 
majority did not report sample VRE09 as being part of 
this cluster. Nevertheless, it was reported by five centres. 
Lastly, C6 is well supported by 12 out of the 13 centres for 
containing sample VRE26, VRE36, VRE37 and VRE39. 
Notwithstanding, centre 7 only reported sample VRE26 with 
VRE36 as being linked.
KP UPGMA tree-of-centres outcome
A UPGMA tree- of- centres (Fig. 1) was used to visualize the 
comparison of each centre’s reported outcome, including 
pipeline description, cluster definition and cluster composi-
tion. Furthermore, trees identified as being the geometric 
median are noted in bold (Fig. 1). For KP, three groups of 
centres reported identical outbreak cluster content, centres 
7 and 12, centres 1 and 11, and centres 2, 4, 6, 8 and 13. 
The latter group of centres reported identical clusters as the 
majority vote. Centres 3, 5, 9 and 10 reported unique cluster 
compositions from any other centre. Centre 5 reported the 
most dissimilar cluster compositions to any other centre in 
this study.
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VRE UPGMA tree-of-centres outcome
The VRE tree- of- centres shows more dissimilarity (median 
64, range 0–283) compared to the KP tree- of- centres 
(median 39, range 0 to 68). Centres 2, 3 and 8 reported 
identical outbreak clusters and content. All other centres 
reported unique outbreak cluster compositions. The VRE 
tree- of- centres clearly shows a large branch for centre 9, 
suggesting that centre 9 reported a very different outbreak 
cluster composition. Centre 9 reported on only four clus-
ters, which included 35 out of the 40 strains. Additionally, 
this centre reported on the biggest individual cluster and 
included 26 strains, which was a composite of C1 (ST203), 
C2 (ST17) and C3 (ST203) (Fig. 2). However, the majority 
of the centres identified three separate cluster: C1, C3 
(ST203) and C2 (ST17) (Fig. 2, Table S3).
Overall outbreak analysis performance
The majority vote and geometric median were calculated to 
evaluate centres’ outbreak analyses outcome. The KP UPGMA 
tree- of- centres reported an identical majority vote and the 
geometric median (Fig.  1). However, there is a difference 
between the majority vote and the geometric median in 
the VRE dataset, highlighting the vast diversity in reported 
clusters.
Centres 2 and 8 reported identical clusters for both the KP 
dataset as well as the VRE dataset. Centre 6 reported compa-
rable clusters to centres 2 and 8. Centre 3 was also reporting 
similar to centres 2, 6 and 8 in both datasets.
Another observation is the type of cluster definitions and its 
wide distribution among centres. For instance, when using cg/
wgMLST schemes, this varied from 7 to 150 alleles difference 
(Fig. 1).
Eight centres used Ridom SeqSphere+, but still, these centres 
reported different outbreak clusters. For the KP and VRE 
dataset, only four and three out of eight centres reported 
identical outcomes, respectively. Moreover, centres that used 
different bioinformatic workflows still were able to report 
identical outbreak clusters.
Fig. 1. UPGMA tree- of- centres for both the KP as the VRE dataset. The trees indicate the relation of reported outbreak outcome of all 
13 centres. Majority and geometric median calculations are added to the UPGMA trees. The data next to the UPGMA trees show the 
bioinformatic workflow used per centre divided in readcleaning, assembly, and outbreak analysis tools. Furthermore, cluster definitions 
applied per centre are plotted in barplots and the outcome of the centres is indicated in the barplots with cluster composition. Legends 
are integrated in the figure.
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Fig. 2. Sample- to- sample relations as reported by the 13 participating centres. The figure is divided in the K. pneumoniae (KP) outcome 
and in the VRE outcome. All samples are named according the naming that was provided throughout the study. Legend of the figure can 
be found in the right corner of the figure. The ST that was reported by the majority of the centres was added at each cluster.
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SNP-cut-off sweep
We standardized the cluster cut- offs to a range of 0 to 150 SNPs 
and used a single outbreak analysis tool (SKA) to remove bias 
that could be introduced by the various different cut- offs used 
by each centre. Hence, the results would give us insights into 
the influence of pre- processing on the outcome of each centre's 
cluster composition. In Fig. 3, the results of this analysis are visu-
alized for all centres except for centre 5, who submitted faulty 
formatted fasta files that could not be analysed. The blue bar 
indicates the mean Kendall–Colijn distances calculated for all 
centres. The red bar indicated the distances between centres 9 
and 12. A Kendall–Colijn distance of 0 would indicate no differ-
ence between the cluster composition between centres. Fig. 3(a, 
c) show that the blue bar plots start with 0 mean Kendall–Colijn 
distance due to the absence of any clusters (data not shown). The 
lowest cut- off to result in a full agreement of cluster composition 
among all centres is 68 cgSNPs in the KP dataset. Overall, the 
cgSNP method (Fig. 3c, d) results in lower mean Kendall–Colijn 
distances and shows a better agreement in cluster composition 
among centres compared to the wgSNP method (Fig. 3a, b).
Centres 9 and 12 use identical tools and near identical 
settings (Fig. 1), Kendall–Colijn distances are indicated by 
the red bars (Fig. 3). The results in Fig. 3 (indicated by the red 
bars) clearly show that the Kendall–Colijn distance is lower 
between centres 9 and 12 compared to the distance between 
all centres (blue bars). The lowest SNP cut- off resulting in 
identical reporting between centre 9 and 12 is 24 cgSNPs for 
the VRE dataset (Fig. 3d) and 28 cgSNPs for the KP dataset 
(Fig. 3c).
Impact on IPC measures
To study these differences in more detail and see the effect 
on potential IPC measures, cut- offs 5, 10, 15 and 20 cgSNPs 
were used to illustrate the differences between the sample- to- 
sample trees of centres 9 and 12 (see Fig. 4). Fig. 4(a) illustrates 
the sample- to- sample trees with a cut- off of five SNPs. Centre 
9 does not have samples clustered for the KP dataset, whereas 
centre 12 already has two clusters of two samples each. For the 
VRE dataset, both centres have samples clustered. However, 
the composition of the clusters is not always identical. For 
instance, centre 12 has a cluster of five samples, of which 
centre 9 reported VRE33 not being part of a cluster and 
VRE13 being part of a different cluster. Furthermore, with 
10, 15 and 20 SNPs (Fig. 4b–d), we also observe differences 
between centres 9 and 12 in outbreak cluster composition for 
both the KP and the VRE datasets.
DISCUSSION
This study aimed to assess the reproducibility of WGS- based 
bacterial outbreak analysis and interpretation in the medical 
microbiology laboratory. Thirteen Dutch hospitals and 
Fig. 3. Sweep cut- off analysis results. The barplots in this figure illustrate the mean differences between the outbreak clusters reported 
among centres. For example, a distance of 0 means that centres reported identical outbreak clusters. The mean distance is calculated 
using the Kendall–Colijn distances metric. (a) Sweep cut- off analysis of the KP samples using the wgSNP method. (b) Sweep cut- off 
analysis of the VRE samples using the wgSNP method. (c) Sweep cut- off analysis of the KP samples using the cgSNP method. (d) sweep 
cut- off analysis of the VRE samples using the cgSNP method.
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university medical centres participated and entered this study 
with the same WGS datasets and reported results for outbreak 
clusters, AMR genes and ST. Hence, any form of variation or 
bias introduced during the sample preparation was mitigated.
Results presented here demonstrated an evident lack of repro-
ducibility among centres, caused by differences in outbreak 
cluster definitions, bioinformatic workflow and quality 
control. The four most important findings were: (i) the large 
variety in cluster definitions leading to a large diversity in 
reported outbreak clusters, which, in the current situation, 
makes it impossible to compare outbreak clusters across 
centres. (ii) In light of the current situation, it is unachievable 
to obtain identical clusters when using a standardized cut- off 
because data processing introduces bias. (iii) The failure of 
detecting specific loci, such as ESBL and housekeeping genes, 
due to mis- assembly and too stringent post- processing. (iv) 
Imprecise data entry leads to erroneous conclusions. In a real- 
world scenario, all these issues will affect outbreak manage-
ment, which impacts patient and healthcare worker safety.
To move the field of clinical bacterial typing and outbreak 
detection forward, we provide guidelines and recommen-
dations based on our findings. These guidelines help to 
establish a workflow that has reproducible outcome, thereby 
minimizing the discrepancies between centres. Yet, we are 
aware this list is far from absolute.
• Tools: All tools used in the bioinformatic workflows should 
be deterministic, if possible, to guarantee fully reproduc-
ible results.
• Verification of species: perform identification of species, 
to ensure proper sample handling.
• Contamination: perform identification of sample compo-
sition using a metagenomic tool [39], as contamination 
will affect analyses.
• AMR detection and MLST typing: perform gene detection 
preferably using a de novo assembly- free method such as 
KMA [30]. This method can detect AMR and housekeep-
ing genes using raw sequence reads as input and measure 
these targets’ sequence depth.
• Automation of pipelines and reporting: the use of a bio-
informatic management system will assist to create repro-
ducible data analyses and facilitates standardize reporting. 
Furthermore, automation will limit manual intervention, 
which is known to be error prone.
• Harmonize workflows: identical workflows ought to be 
used to be able to compare, share and integrate data.
Fig. 4. Illustration of differences in sample- to- sample relations between centre 9 and centre 12. This figure illustrates for a sweep cut- off 
of 5, 10, 15 and 20 SNPs using the cgSNP method the differences in outbreak cluster composition between centre 9 and centre 12. Both 
given for the KP as well as the VRE samples.
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Outbreak cluster comparison
The differences in reported outbreak cluster composition 
among centres cannot be strictly appointed to the use of 
specific tools. No clear relation between reported cluster 
outcome and use of tool or methodology was observed 
(Fig. 1). Three groups of centres (centres 2, 4, 6 and 8; centres 
1 and 11; centres 7 and 12) used different tools for outbreak 
analyses yet reported identical cluster compositions. On the 
contrary, not all centres using Ridom Seqsphere+ (eight out 
of thirteen centres) reported identical cluster composition. 
Based on these contradictory results, we cannot appoint the 
effect of a particular tool on cluster composition.
To exclude the possibility that all bias was introduced using 
different thresholds or different outbreak analysis tools, we 
used a single tool and a range of thresholds to determine 
the cluster composition of the assemblies generated in each 
centre. This analysis clearly illustrated that using a single 
outbreak analysis tool and defining standardized SNP cut- 
offs is not sufficient to obtain identical cluster compositions, 
since the impact of pre- processing already heavily impacts 
the cluster outcome (Fig. 3). Even when comparing the two 
most closely related centres in terms of methodology and 
tools used, we still observe differences in outcome, leading 
to significant implications for outbreak management and IPC. 
Fig. 4 highlights the differences in outcome in a sample- to- 
sample comparison. These findings support the need for a 
more standardized way of bacterial outbreak analysis to 
circumvent most of these short- comings.
In our final analysis, we focused on SNP analysis and deter-
mining outbreak clusters using SNP cut- offs. These cut- offs 
are often calculated ad hoc [15, 40] and differ significantly 
among studies [41]. Combined with our findings, we can 
conclude that using these cut- offs when using non- identical 
bioinformatic outbreak analysis workflows is futile. Other 
analysis strategies have been proposed, for example, a method 
that uses a probabilistic method to infer transmissions to help 
solving these [42].
ST
All centres were in excellent concordance on the STs of 
the strains used in this study, however reporting- errors 
were detected for two VREs strains (VRE18 and VRE33), 
potentially impacting the final epidemiological assessment. 
All but one centre reported these two strains as ST17 and 
ST203, common nosocomial VRE [43–45]. One centre 
classified these two strains to an ST with an absent pstS, 
one of the seven genes in the MLST scheme for E. faecium. 
This would indicate the presence of rare types of VRE. 
However, no pstS- null vanB VRE has been reported, and 
only recently, the first non- typeable VRE isolates associated 
with a pstS- null genotype carrying a vanA cassette have 
been described in Australia, Korea and Scotland [38, 46, 47]. 
The misinterpretation was introduced by mis- assembly or 
too stringent post- processing and may lead to different 
interpretations when reporting on routine surveillance or 
bacterial outbreaks.
AMR
Not all centres reported on the presence of specific beta- 
lactamase genes. Also, high variation was observed in the 
reported SHV genes. Many, but not all, of these blaSHV genes 
result in an ESBL phenotype [48]. In addition, not all blaCTX- M 
genes were recovered by some centres. In a study investigating 
the reproducibility of AMR gene reporting, Doyle et al. 
reported similar discordance. However, the discordance in 
the reported gene variant was only minor in the genotypic 
resistance prediction [26]. Contradictory, in our study, both 
discordance in the gene variant reporting and false absence 
of ESBL genes was observed. Although we did not request 
genotypic resistance prediction reporting, failure to detect 
ESBL genes will influence resistance prediction. This can be of 
major impact as international guidelines advise contact isola-
tion for patients carrying ESBL Enterobacteriaceae [49]. This 
problem is minor in practice, as strains are commonly pheno-
typically characterized for their AMR profile in a clinical 
microbiology laboratory. Analysis of how the false absence 
of the ESBL genes occurred demonstrated that centres that 
missed ESBL genes (blaCTX- M-14) removed all small contigs 
of up to 1 kb during post- processing. Resistance genes are 
often located on transposons or plasmids, which are difficult 
to assemble using short- read sequencing data. These hard to 
assemble regions can then be assembled into small contigs, 
sometimes of <1 kb, which would be removed by stringent 
post- processing. Normally, small contigs are removed as they 
are often associated with contamination. To overcome the 
failure of detecting AMR genes, one could use an assembly- 
free method such as KMA [30] or ARIBA [50] or simply 
retain these small contigs.
Data entry
This study evaluates the reporting of AMR, ST and outbreak 
clusters, performed by molecular trained staff, to IPC teams, 
thereby mimicking a crucial procedure in outbreak manage-
ment. However, in this study, we found multiple incidences 
of inaccurate or incorrect reporting of results, such as, (i) 
swapping of samples KP12 with KP13 and KP23 with KP24 by 
centre 3, and, (ii) incomplete reporting of sample- to- sample 
relations, which mainly occurred by centre 9 in the VRE 
dataset (data not shown). These flaws in data entry can have 
significant consequences for IPC. It may result in extra costs 
and could potentially miss or identify new faulty outbreaks, 
leading to further transmission and follows into the closure of 
hospital wards, lack of patient safety and even loss of human 
lives [51]. When implementing WGS procedures, medical 
microbiology laboratories should carefully follow interna-
tional norms and guidelines relating to data management 
[52].
Limitations
We are aware that this study is focused on the dry- lab part of 
outbreak analysis, thereby not taking into account the wet- lab. 
Assessing the combination of wet- and dry- lab will result in 
even larger discrepancies than observed in our study. To date, 
little effort has been conducted to assess the reproducibility 
10
Coolen et al., Microbial Genomics 2021;7:000612
of outbreak analyses in a clinical context. Wet- lab reproduc-
ibility has been previously evaluated but all used a single 
bioinformatic analysis method [24, 53]. Notwithstanding, 
the current situation is that centres in the Netherlands that 
adopted WGS- based outbreak analyses use a plethora of 
bioinformatic workflows. As a result, centres may communi-
cate outcomes to each other without knowing if these results 
are interchangeable and may not be reproducible. Moreover, 
communicating outbreaks to national reference laboratories 
for surveillance and monitoring purposes is essential to miti-
gate nationwide outbreaks and prevent further spread.
CONCLUSION
To conclude, our study demonstrates limited reproducibility 
among centres applying WGS for bacterial outbreaks and 
AMR detection in the Netherlands. This will inevitably nega-
tively impact IPC, healthcare workers’ and patients’ health and 
safety. Therefore, we advise the need for more collaboration 
among centres to better assess outbreaks and AMR detection 
through optimization and harmonization of bioinformatic 
tools. This would include extensive proficiency testing, open- 
source data sharing and formulation of guidelines [54]. Even-
tually, leading to harmonization of protocols and guidelines 
to minimize centre- to- centre variability. Furthermore, we 
provided guidelines for bioinformatic workflow setup, which 
would address most of the issues detected in this study.
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